Keiko Iwahara Greenberg

Keiko Greenberg practices at Union Plaza Dialysis Center in Washington, District of Columbia.

Keiko Greenberg's NPI, 1588807408, was assigned on April 7, 2009. Keiko Greenberg graduated from University of Virginia School of Medicine in 2009. Keiko Greenberg holds Maryland license D0079185.

Keiko Greenberg's primary practice is Union Plaza Dialysis Center, at 3301 New Mexico NW Ave, Washington, DC 20016 in District Of Columbia County. The practice phone is (202) 842-3127.

Keiko Greenberg's primary practice is Union Plaza Dialysis Center in Washington, District of Columbia. Keiko Greenberg is also affiliated with MedStar Georgetown University Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Keiko Greenberg to 2 more dialysis centers, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Keiko Greenberg practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Keiko Greenberg's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Keiko Greenberg is licensed in Maryland.

CMS data shows 1,152 Medicare services from Keiko Greenberg across 13 procedure codes in 2024, for 333 Medicare patients. Medicare paid $120,504 for them.

CMS counts 333 Medicare patients who saw Keiko Greenberg in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 38% are also on Medicaid. Their average risk score is 4.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Keiko Greenberg's median patient age at 62, with 39% women.

In 2024, Keiko Greenberg wrote 655 Medicare Part D claims for 88 patients. 86% of them were for generic drugs. CMS names the drug for 355 of them, across 16 drugs with 11 or more claims each, at $43,486 in total drug cost. In 2023, CMS named 233 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Keiko Greenberg for performance year 2024, reported as part of a group. Keiko Greenberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Keiko Greenberg as offering telehealth.

CMS Open Payments shows 7 general payments to Keiko Greenberg from 5 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Travere Therapeutics, Inc. paid the most, $247.

Keiko Greenberg graduated from University of Virginia School of Medicine in 2009.